Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 5:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 2,293 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Coronary Artery Disease
Interventions: aspirin plus clopidogrel, prasugrel or ticagrelor; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Coronary Artery Disease, Hypertension, Dyslipidemia, Diabetes
Interventions: magnesium L-lactate; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Atherosclerosis, Coronary
Interventions: Drug Infusion (BQ-123); Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chest Pain, Myocardial Infarction, Myocardial Ischemia, Acute Coronary Syndrome
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 6,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Atherosclerosis, Coronary
Interventions: CCTA; Diagnostic Test
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Arteriosclerosis of Coronary Artery Bypass Graft, Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Coronary Artery Disease, Valvular Heart Disease, Aorta Disease, Heart Failure
Interventions: Sugammadex administration; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Coronary Artery Disease
Interventions: Coronary stent; Device
Lead sponsor: Cook Group Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Defibrillators, Implantable, Myocardial Infarction, Tachycardias, Ventricular
Interventions: ICD; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 2,047 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Acute Coronary Syndrome
Interventions: Apolipoprotein A-I [human] (apoA-I), Placebo; Biological · Other
Lead sponsor: CSL Behring; Industry
Eligibility: 18 Years and older
Enrollment: 18,226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 202
States / cities: Alexander City, Alabama • Birmingham, Alabama • Huntsville, Alabama + 175 more

Conditions: Heart Failure, Congestive
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Erectile Dysfunction Due to Arterial Insufficiency
Interventions: Not listed
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 35 Years to 70 Years · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Coronary Artery Disease
Interventions: Traditional Acupuncture, AA; Procedure
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiovascular Diseases, Heart Diseases, Obesity
Interventions: Exercise; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Myocardial Ischemia
Interventions: Celution System, Placebo; Device
Lead sponsor: Cytori Therapeutics; Industry
Eligibility: 20 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Disease, Coronary Stenosis
Interventions: ICA (Invasive Coronary Angiography), OCT, FFR, VFR Analysis; Procedure · Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 28
States / cities: Huntsville, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 22 more

Conditions: Myocardial Infarct
Interventions: RNS60, Placebo; Drug
Lead sponsor: Revalesio Corporation; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Coronary Artery Disease, Chronic Obstructive Pulmonary Disease
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Coronary Artery Disease, Endothelial Dysfunction
Interventions: Music therapy; Other
Lead sponsor: Emmanouil Brilakis; Federal
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Coronary Artery Disease
Interventions: BFPET; Drug
Lead sponsor: Fluoropharma, Inc.; Industry
Eligibility: 20 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Coronary Syndrome
Interventions: Lixisenatide (AVE0010), Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 30 Years and older
Enrollment: 6,068 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 200
States / cities: Birmingham, Alabama • Foley, Alabama • Mobile, Alabama + 160 more

Conditions: Coronary Disease, Heart Diseases
Interventions: Myocardial contrast echocardiography, Dobutamine echocardiography; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Coronary Artery Disease
Interventions: Inclisiran sodium 300 mg, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 27
States / cities: Huntsville, Alabama • Anchorage, Alaska • Beverly Hills, California + 22 more

Conditions: Coronary Artery Disease
Interventions: percutaneous coronary intervention; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 1,326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries

ECG Methods for the Prompt Identification of Coronary Events

Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.

Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)

Sugammadex Titration in Cardiac Surgery Patients

The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial

Risk of Life-threatening Heart Rhythm Disturbances in Siblings

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism

Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study

The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease

Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults

Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting

Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy

A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent